Luigi Bolondi
#128,430
Most Influential Person Now
Researcher
Luigi Bolondi's AcademicInfluence.com Rankings
Luigi Bolondimathematics Degrees
Mathematics
#6172
World Rank
#8598
Historical Rank
Group Theory
#61
World Rank
#78
Historical Rank
Algebra
#191
World Rank
#290
Historical Rank
Measure Theory
#1176
World Rank
#1500
Historical Rank
Download Badge
Physics Mathematics
Luigi Bolondi's Degrees
- PhD Physics University of Milan
- Masters Mathematics University of Bologna
Why Is Luigi Bolondi Influential?
(Suggest an Edit or Addition)Luigi Bolondi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sorafenib in advanced hepatocellular carcinoma. (2008) (5771)
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma (2018) (1362)
- Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. (1995) (946)
- Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. (2007) (818)
- Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. (2008) (792)
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. (2016) (784)
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. (2012) (707)
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. (2015) (697)
- The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. (2006) (693)
- Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis (2001) (673)
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma (2008) (634)
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions (2012) (554)
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. (2011) (490)
- Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma (2005) (441)
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma (2014) (432)
- Guidelines for the use of contrast agents in ultrasound. January 2004. (2004) (421)
- Measurement of gastric emptying time by real-time ultrasonography. (1985) (420)
- Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival (1992) (417)
- MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. (2010) (401)
- Percutaneous etharrol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients (1992) (385)
- MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. (2009) (383)
- Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria (2008) (331)
- Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis (2018) (320)
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality (2009) (312)
- Oncogenic role of miR-483-3p at the IGF2/483 locus. (2010) (292)
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. (2013) (289)
- Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. (2019) (282)
- No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. (1995) (281)
- MicroRNA involvement in hepatocellular carcinoma (2008) (261)
- What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. (1997) (253)
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study. (2018) (249)
- Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance (2004) (234)
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas (2011) (228)
- Screening for hepatocellular carcinoma in cirrhosis. (2003) (223)
- Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study. (2013) (215)
- The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria (2010) (212)
- Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. (1982) (210)
- Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression (2005) (203)
- Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. (1991) (191)
- In hepatocellular carcinoma miR‐519d is up‐regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 (2012) (190)
- Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma (2012) (190)
- Liver cirrhosis: changes of Doppler waveform of hepatic veins. (1991) (189)
- Interobserver and interquipment variability of echo‐doppler examination of the portal vein: Effect of a cooperative training program (1995) (183)
- Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis (2011) (182)
- Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population (2009) (180)
- Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. (2013) (172)
- Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. (1990) (168)
- Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. (1992) (163)
- Small hepatocellular carcinoma: percutaneous alcohol injection--results in 23 patients. (1988) (155)
- Triple Antiviral Therapy as a New Option for Patients With Interferon Nonresponsive Chronic Hepatitis C (2000) (154)
- Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. (1991) (152)
- Liver tumorigenicity promoted by microRNA‐221 in a mouse transgenic model (2012) (151)
- Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: A long‐term prospective study (1999) (147)
- The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. (2017) (143)
- Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease (1989) (141)
- Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. (2004) (135)
- Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC (2015) (132)
- Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. (2011) (131)
- Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma (2018) (131)
- Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index (2000) (129)
- Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. (2008) (127)
- Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". (2012) (123)
- Significance of serum and hepatic microRNA‐122 levels in patients with non‐alcoholic fatty liver disease (2014) (123)
- In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis (2017) (121)
- Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis. (1997) (112)
- Partial Necrosis on Hepatocellular Carcinoma Nodules Facilitates Tumor Recurrence after Liver Transplantation (2004) (112)
- Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. (2017) (111)
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study (2014) (111)
- New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm (2018) (109)
- Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation (2010) (109)
- Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery. (1985) (109)
- Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma (2007) (107)
- Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer (2004) (107)
- Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. (2013) (104)
- Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial. (2018) (103)
- Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics (2004) (102)
- Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis (2015) (100)
- Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound (2013) (98)
- Oxidative Stress EPR Measurement in Human Liver by Radical-probe Technique. Correlation with Etiology, Histology and Cell Proliferation (2002) (98)
- Impact of gadoxetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective study (2013) (97)
- Cyclin G 1 Is a Target of miR-122 a , a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma (2007) (96)
- Hepatocellular carcinoma: epidemiology and clinical aspects. (2008) (95)
- Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. (2000) (95)
- Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. (1992) (92)
- Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. (1995) (91)
- Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? (2013) (89)
- Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. (2009) (88)
- Intraoperative ultrasonography in surgery for liver tumors. (1986) (85)
- Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease (2006) (81)
- Characterization of liver lesions by real-time contrast-enhanced ultrasonography (2007) (80)
- New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. (2007) (79)
- Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. (2009) (78)
- Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer (2007) (78)
- Primary gastric lymphoma versus gastric carcinoma: endoscopic US evaluation. (1987) (77)
- Endoscopic ultrasonography in the diagnosis of gastric submucosal tumor. (1989) (77)
- Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma. (1997) (76)
- Accuracy and reproducibility of portal flow measurement by Doppler US. (1991) (75)
- High Prevalence of Helicobacter pylori in Liver Cirrhosis (Relationship with Clinical and Endoscopic Features and the Risk of Peptic Ulcer) (1997) (74)
- Ultrasonographic study of portal venous system in portal hypertension and after portosystemic shunt operations. (1984) (72)
- Characterization of focal liver lesions with contrast-enhanced ultrasound. (2010) (72)
- Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients (2012) (71)
- Metabolic Syndrome (2006) (70)
- Timing of the first variceal hemorrhage in cirrhotic patients: Prospective evaluation of doppler flowmetry, endoscopy and clinical parameters (1994) (70)
- Value of splanchnic Doppler ultrasound in the diagnosis of portal hypertension. (2001) (70)
- Characterization of Primary and Recurrent Nodules in Liver Cirrhosis Using Contrast-Enhanced Ultrasound: Which Vascular Criteria Should Be Adopted? (2013) (69)
- Detection of portal hypertension and esophageal varices by means of endoscopic ultrasonography. (1986) (67)
- Liver Transplantation with the Meld System: A Prospective Study from a Single European Center (2006) (67)
- Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib (2016) (66)
- Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. (1988) (65)
- Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma (2018) (65)
- The value of Doppler US in the study of hepatic hemodynamics. Consensus conference (Bologna, Italy, 12 September, 1989). (1990) (65)
- Consensus Report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging (2011) (63)
- Clinical and diagnostic aspects of gluten related disorders. (2015) (62)
- The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma (2018) (61)
- Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma. (2010) (59)
- Intra- and extrahepatic arterial resistances in chronic hepatitis and liver cirrhosis. (1997) (59)
- Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study. (2013) (58)
- Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. (2014) (58)
- STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) (2014) (58)
- Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. (1984) (58)
- Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders. (1999) (57)
- Measurement of oxidative stress in human liver by EPR spin-probe technique (2000) (57)
- The intermediate hepatocellular carcinoma stage: Should treatment be expanded? (2010) (56)
- Sonography of chronic pancreatitis. (1989) (55)
- Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular Carcinoma (2015) (55)
- CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma. (2012) (55)
- Mutated β-catenin evades a microRNA-dependent regulatory loop (2011) (54)
- Serum xanthine oxidase in human liver disease (2001) (54)
- Interobserver and inter‐equipment variability of echo‐Doppler sonographic evaluation of the superior mesenteric artery. (1996) (54)
- Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study. (2017) (54)
- Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. (2005) (54)
- The relationship of endoscopy, portal Doppler ultrasound flowmetry, and clinical and biochemical tests in cirrhosis. (1994) (52)
- Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma (2001) (52)
- Problems and variations in the interpretation of the ultrasound feature of the normal upper and lower GI tract wall. (1986) (51)
- Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities (2000) (51)
- Ultrasonic endoscopy--the gastrointestinal wall. (1984) (50)
- Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. (2015) (49)
- Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. (2019) (48)
- A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end‐stage liver disease system (2007) (47)
- In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. (2003) (46)
- Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. (2005) (46)
- Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors (2006) (46)
- Doppler flowmetry in portal hypertension (1990) (46)
- Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. (2009) (44)
- Relationship Between Morphological Changes Detected by Ultrasonography and Pancreatic Exocrine Function in Chronic Pancreatitis (1987) (44)
- The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series (2014) (44)
- The sonographic appearance of the normal gastric wall: an in vitro study. (1986) (43)
- p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma (2013) (43)
- Patterns of gastric emptying in dysmotility-like dyspepsia. (1995) (43)
- Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma (2016) (42)
- Interleukin-1β and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study (2006) (41)
- LncRNAs as novel players in hepatocellular carcinoma recurrence (2018) (41)
- Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma (2013) (41)
- TACE performed in patients with a single nodule of Hepatocellular Carcinoma (2014) (40)
- Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial (2020) (40)
- Second-line tivantinib (ARQ 197) vs placebo in patients (Pts) with MET-high hepatocellular carcinoma (HCC): Results of the METIV-HCC phase III trial. (2017) (40)
- Clinical trial: peg‐interferon alfa‐2b and ribavirin for the treatment of genotype‐1 hepatitis C recurrence after liver transplantation (2008) (39)
- Vascularity of liver tumours and recent advances in doppler ultrasound. (2001) (39)
- Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis (1991) (39)
- Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. (2014) (39)
- Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation (1998) (39)
- Sensitivity of endoscopic retrograde pancreatography in chronic pancreatitis (1982) (39)
- Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma (2014) (38)
- Technique of endoscopic ultrasonography investigation: esophagus, stomach and duodenum. (1986) (37)
- Notch3 intracellular domain accumulates in HepG2 cell line. (2006) (36)
- GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. (2005) (36)
- Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices (2000) (36)
- Molecular Adsorbent Recirculating System (MARS) Application in Liver Failure: Clinical and Hemodepurative Results in 22 Patients (2006) (35)
- Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors (2018) (34)
- Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver. (1996) (34)
- Loss of methylation at chromosome 11p15.5 is common in human adult tumors (2002) (34)
- Impact of endoscopic ultrasonography on diagnosis and treatment of primary gastric lymphoma. (1988) (34)
- Liver AL amyloidosis as a possible cause of high liver stiffness values. (2010) (34)
- MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma (2017) (34)
- Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives (2016) (33)
- Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC). (2016) (33)
- Sonographic Findings in Abdominal Hereditary Angioedema (1999) (33)
- A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease (2017) (33)
- Morphological and hemodynamic changes in the portal venous system after distal splenorenal shunt: An ultrasound and pulsed doppler study (1988) (33)
- Mars and Prometheus: our clinical experience in acute chronic liver failure. (2008) (32)
- Influence of liver fibrosis on hepatic artery Doppler resistance index in chronic hepatitis of viral origin. (2001) (32)
- MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma (2020) (32)
- Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. (2003) (32)
- Associations of the −174 G/C Interleukin-6 Gene Promoter Polymorphism with Serum Interleukin 6 and Mortality in the Elderly (2005) (31)
- Treatment of hepatocellular carcinoma in Child-Pugh B patients. (2013) (31)
- Early diagnosis of hepatocellular carcinoma in Italy. A summary of a consensus development conference held in Milan, 16 November 1990 by the Italian Association for the Study of the Liver (AISF). (1992) (31)
- Influence of the Spleen on Portal Haemodynamics: a Non-invasive Study with Doppler Ultrasound in Chronic Liver Disease and Haematological Disorders (2002) (31)
- Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases (2013) (30)
- Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax. (2008) (30)
- Small (≤3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT (2009) (29)
- Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. (2008) (29)
- TP53/MicroRNA Interplay in Hepatocellular Carcinoma (2016) (28)
- From liver cirrhosis to HCC (2011) (27)
- Diagnosis and management of hepatic focal nodular hyperplasia. (2007) (27)
- A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade (2006) (27)
- Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma. (2012) (27)
- Clinical Impact of Ultrasound-Related Techniques on the Diagnosis of Focal Liver Lesions (2012) (26)
- MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma. (2017) (26)
- Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver (2000) (26)
- Endoscopic retrograde cholangiography (ERC) through artificial endoscopic choledocho-duodenal fistula. (1978) (25)
- Loss of methylation at chromosome 11p15.5 is common in human adult tumors. (2002) (25)
- Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma (2016) (25)
- Liver transplantation for HCC. Treatment options on the waiting list (2003) (25)
- Diagnostic and prognostic value of dna ploidy and cell nuclearity in ultrasound‐guided liver biopsies (1994) (24)
- Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. (2008) (24)
- Anatomical aspects in ultrasonic endoscopy for the stomach. (1984) (23)
- Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors (2005) (23)
- Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification (2010) (23)
- Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients (2019) (23)
- Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. (2008) (22)
- Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. (2012) (22)
- Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma. (2014) (22)
- Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. (1999) (21)
- Refining sorafenib therapy: lessons from clinical practice. (2015) (21)
- Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation (2008) (21)
- In hepatocellular carcinoma AgNOR protein expression correlates with tumour mass doubling time. (1996) (21)
- Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial. (2019) (21)
- Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma. (2015) (21)
- Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end‐stage cirrhosis (2007) (21)
- Secretin administration induces a dilatation of main pancreatic duct (1984) (21)
- Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study. (2017) (20)
- Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. (2010) (20)
- Sonographic diagnosis of adult intussusception (2001) (20)
- Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging (2015) (20)
- Ultrasound detection of unusual spontaneous portosystemic shunts associated with uncomplicated portal hypertension. (1985) (20)
- Long term effects of gluten-free diet in non-celiac wheat sensitivity. (2017) (20)
- The capsule surrounding primary liver tumors: Wherefrom its prognostic significance? (1990) (20)
- Sonographic appearance of pseudomembranous colitis. (1985) (20)
- Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma (2019) (19)
- Circadian occurrence of variceal bleeding in patients with liver cirrhosis (1996) (19)
- Abnormal brain energy metabolism shown by in vivo phosphorus magnetic resonance spectroscopy in patients with chronic liver disease (2002) (19)
- Sonographic assessment of the distal end of the thoracic duct in healthy volunteers and in patients with portal hypertension. (1995) (19)
- Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness. (2012) (19)
- Recent advances in the diagnosis of hepatocellular carcinoma (2007) (19)
- 292 IN HEPATOCELLULAR CARCINOMA MIR-519D IS UPREGULATED BY P53 AND DNA HYPOMETHYLATION (2012) (19)
- Hemodynamics in focal nodular hyperplasia. (1999) (18)
- Fibromyalgia and coeliac disease: a media hype or an emerging clinical problem? (2013) (18)
- Caution in the use of boldo in herbal laxatives: A case of hepatotoxicity (2005) (18)
- Review article: percutaneous treatment of hepatocellular carcinoma. (2003) (18)
- A modeling study of bilirubin kinetics during Molecular Adsorbent Recirculating System sessions. (2006) (17)
- Percutaneous treatment of hepatocellular carcinoma (2003) (17)
- Radiologic criteria of response to systemic treatments for hepatocellular carcinoma. (2017) (17)
- An evaluation of echography in the diagnosis of pancreatic disease. (1976) (16)
- Caliber of splenic and hepatic arteries and spleen size in cirrhosis of different etiology. (2008) (16)
- Influence of esophageal varices and spontaneous portal-systemic shunts on postprandial splanchnic hemodynamics (2001) (16)
- Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population. (1990) (16)
- Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials (2017) (16)
- Effect of secretin on portal venous flow. (1990) (16)
- The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. (2004) (16)
- 6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma (2011) (16)
- Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. (2008) (16)
- Knowledge of the bio-effects of ultrasound among physicians performing clinical ultrasonography: Results of a survey conducted by the Italian Society for Ultrasound in Medicine and Biology (SIUMB). (2009) (15)
- Quantitative analysis of intrahepatic bile duct component in normal adult human liver and in primary biliary cirrhosis. (1994) (15)
- Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) (1997) (15)
- miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature (2017) (15)
- Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. (1997) (15)
- Left ventricular volumes in liver cirrhosis. (2000) (15)
- Hepatocellular adenoma: An unsolved diagnostic enigma (2019) (15)
- Multigene Methylation Analysis of Gastrointestinal Tumors (2012) (14)
- Final results from ARQ 197-114: A phase Ib safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC). (2010) (14)
- Ultrasonography and guided biopsy in the diagnosis of hepatocellular carcinoma. (1992) (14)
- Ultrasound in the diagnosis of cholestatic jaundice. (1979) (13)
- Liver cirrhosis, ascites, and hyperfibrinolysis (2001) (13)
- Portohepatic vascular pathology and liver disease: diagnosis and monitoring. (1998) (13)
- Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis. (2006) (13)
- Diathermy ERCP: an alternative method for endoscopic retrograde cholangiopancreatography (ERCP) in jaundiced patients. (1980) (13)
- Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis. (2007) (13)
- Diagnosis of islet cell tumor by means of endoscopic ultrasonography. (1990) (13)
- A case of aneurysm of the splenic artery visualized by dynamic ultrasonography. (1981) (13)
- Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers (2015) (12)
- Management of small hepatocellular carcinoma. (2006) (12)
- The value of ultrasonography in the diagnosis of hepatic haemangiomas. (1983) (12)
- The appropriate allocation of CEUS in the diagnostic algorithm of liver lesions: a debated issue. (2013) (12)
- Durable Complete Response of Hepatocellular Carcinoma after Metronomic Capecitabine (2010) (12)
- Prospective, open-label, multi-centre study evaluating the accuracy of unenhanced versus SonoVue® enhanced ultrasonography (US) in the characterisation of focal liver lesions (2003) (12)
- Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma (2017) (11)
- Liver metastases from rectal carcinoma: Disease progression during chemotherapy despite loss of arterial‐phase hypervascularity on real‐time contrast‐enhanced harmonic sonography at low acoustic energy (2003) (11)
- Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. (2007) (11)
- A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. (2011) (11)
- Impaired response of main pancreatic duct to secretin stimulation in early chronic pancreatitis (1989) (11)
- ARQ 197-215: A randomized, placebo-controlled phase II clinical trial evaluating the c-Met inhibitor, ARQ 197, in patients (pts) with hepatocellular carcinoma (HCC). (2010) (10)
- Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma (2018) (10)
- From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma (2018) (10)
- The chronically ill elderly patients discharged from the hospital: interim report from a controlled study of home care attendance. (2004) (10)
- Possible mechanisms for changes of intrasplenic arterial impedance indices in portal hypertension (1997) (10)
- 109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B) (2013) (10)
- AISF practice guidelines for portal hypertension. Committee for Portal Hypertension of the Italian Association for the Study of the Liver (AISF). (1999) (10)
- Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC). (2018) (10)
- Outcomes from a program of home care attendance in very frail elderly subjects. (2007) (10)
- Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals. (2018) (9)
- Primary non-Hodgkin's T-Cell lymphoma of the esophagus (1990) (9)
- Regorafenib for the treatment of hepatocellular carcinoma. (2018) (9)
- Doppler evaluation of the effects of pharmacological treatment of portal hypertension. (1999) (9)
- Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification (2018) (9)
- Outcomes in patients (pts) who had received sorafenib (S) as the only prior systemic therapy in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC). (2018) (9)
- [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis]. (1997) (9)
- Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma (2014) (9)
- Changes in the hepatic vein waveform detected by doppler us in liver cirrhosis (1989) (9)
- Medical Treatment of Hepatocellular Carcinoma (2009) (8)
- Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis (2018) (8)
- Early Prediction of Treatment Response to Sorafenib with Elastosonography in a Mice Xenograft Model of Hepatocellular Carcinoma: A Proof-of-Concept Study (2013) (8)
- AISF practice guidelines for portal hypertension (1999) (8)
- Doppler Flowmetry—Clinical Applications in Portal Hypertensive Patients (1991) (8)
- Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis (2016) (8)
- Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma. (2016) (8)
- Allelic Imbalance on 16q in Small, Unifocal Hepatocellular Carcinoma (2000) (7)
- Alteration of DNA ploidy and cell nuclearity in human hepatocellular carcinoma associated with HBV infection. (1996) (7)
- CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules (2017) (7)
- Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to positron emission tomography scan. (2007) (7)
- Gallstone ileus in Caroli's disease (2000) (7)
- ULTRASONOGRAPHY IN ASSESSMENT OF PORTAL VENOUS SYSTEM (1978) (7)
- Improvement of pancreatic ultrasound imaging after secretin administration. (1983) (6)
- Contrast enhanced ultrasonography for the evaluation of coil embolization of splenic artery aneurysm. (2010) (6)
- 3. Ding H, Wang WP, Huang BJ. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005;24:285-97. (2012) (6)
- Cirrhosis does not shift the circadian phase of plasma fibrinolysis (2002) (6)
- Brivanib in combination with Notch3 silencing shows potent activity in tumour models (2019) (6)
- Clinico-Pathological Classification (2005) (5)
- Hepatic resection for tumours in cirrhotic livers. (1987) (5)
- Functional Ultrasonography in Gastroenterology (1988) (5)
- Cytochemical detection of a class 3 aldehyde dehydrogenase in human hepatocellular carcinoma. (2008) (5)
- Cirrhosis does not shift the circadian phase of plasma fibrinolysis. (2002) (5)
- Eosinophilic granulomatosis with polyangiitis of the major salivary glands: a case of sialadenitis in a young patient. (2013) (5)
- Caution in the interpretation of Doppler signals of HCC. (1990) (5)
- Response to triple antiviral therapy in interferon non-responders with chronic hepatitis C (1998) (5)
- 265 COST-EFFECTIVENESS OF HEPATIC RESECTION VERSUS PERCUTANEOUS ABLATION FOR HEPATOCELLULAR CARCINOMA WITHIN THE MILAN CRITERIA (2013) (5)
- 614 SPLENIC STIFFNESS ASSESSED BY ARFI (ACOUSTIC RADIATION FORCE IMAGING) CORRELATES WITH PORTAL PRESSURE IN CIRRHOSIS (2012) (4)
- Metronomic capecitabine in advanced patients with hepatocellular carcinoma (HCC): Preliminary results (2007) (4)
- Contrast-enhanced ultrasound in liver cancer. (2015) (4)
- Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis (1996) (4)
- Changes in mesenteric venous flow due to celiac sprue (1992) (4)
- Yttrium 90 radioembolization: The horizon is changing for patients with intermediate and advanced hepatocellular carcinoma (2013) (4)
- DAAs for HCV and risk of hepatocellular carcinoma: current standpoint. (2018) (4)
- "Survival benefit": the final destination, with still a long way to go. (2010) (4)
- Ultrasonographic findings in portal hypertension: correlation with the presence and size of oesophageal varices. (1983) (4)
- Doppler Ultrasound in Portal Hypertension (1997) (4)
- Hepatocellular Carcinoma : A Practical Approach (2009) (4)
- Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection (2013) (4)
- Morphological bases of splenic circulation in congestive splenomegaly. (1985) (4)
- Autoimmune Hepatitis and Celiac Disease: Case Report Showing an Entero-Hepatic Link (2010) (4)
- Prediction of significant fibrosis in chronic hepatitis C patients by artificial neural network analysis of clinical factors (2007) (4)
- Critical Evaluation and Controversial Points of Ultrasound Findings in Chronic Pancreatitis (1986) (4)
- Diagnosis of Cirrhosis and Portal Hypertension (1998) (4)
- Reliability of ultrasound screening of liver and kidney donors: a retrospective study. (2000) (3)
- P0340 : Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): A multicenter case-control study (2015) (3)
- Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals (2018) (3)
- In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance (2016) (3)
- A Western Case of Intravascular Large B-Cell Lymphoma as Unusual Cause of Persistent Fever (2019) (3)
- Primary non-Hodgkin's T-cell lymphoma of the esophagus. A case with peculiar endoscopic ultrasonographic pattern. (1990) (3)
- MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis Predicts Sorafenib Resistance in Hepatocellular (3)
- Cardiac abnormalities in Cirrhosis (2001) (3)
- Down-regulated in Human Hepatocellular Carcinoma Cyclin G 1 Is a Target of miR-122 a , a MicroRNA Frequently (2007) (3)
- Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. (2004) (3)
- State of the art: hepatocellular carcinoma. (2014) (3)
- Orthotopic liver transplantation (OLT): Contribution of imaging and interventional radiology in preparing the transplantation and managing complications. Part 2: Post-OLT complications and their treatment. (2005) (3)
- Diagnostic Ultrasound in Gastroenterology: Instrumentation, Clinical Problems and Atlas (1984) (3)
- [Etiopathogenetic aspects of chronic pancreatitis]. (1977) (3)
- Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease (2022) (3)
- Onset of bronchiolitis obliterans organizing pneumonia in a liver transplant recipient under peg-interferon and ribavirin treatment (2008) (3)
- Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm (2004) (3)
- Selecting patients with hepatocellular carcinoma for transplantation (2007) (3)
- Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation (2007) (3)
- Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. (2008) (3)
- Study of the effect of neurotensin on meal- and cerulein-induced gallbladder contraction. (1992) (3)
- BIOMARKER RESULTS FROM ARQ 197-114: A PHASE 1B TRIAL EVALUATING THE c-MET INHIBITOR ARQ 197 IN CIRRHOTIC PATIENTS (PTS) WITH HEPATOCELLULAR CARCINOMA (HCC) (2010) (3)
- Screening tests for hepatocellular carcinoma (2003) (3)
- Durable Complete Response of Hepatocellular Carcinoma after Metronomic Capecitabine (2010) (3)
- Sudden change in the sonographic appearance of a thyroid cyst after percutaneous aspiration (1989) (2)
- A randomized phase III trial comparing sorafenib plus best supportive care (BSC) versus BSC alone in Child-Pugh B patients (pts) with advanced hepatocellular carcinoma (HCC): The BOOST study. (2012) (2)
- Effect of Levovist on splanchnic hemodynamics in cirrhotic patients. (2003) (2)
- Stiffness and amyloidosis: to be continued…. (2010) (2)
- Posters Presentations (2022) (2)
- Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma q (2008) (2)
- Ultrasonography in the diagnosis of cholestatic jaundice. Comparison with endoscopic retrograde cholangio-pancreatography. (1978) (2)
- Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study (2015) (2)
- 135 Staging of hepatic fibrosis by liver elastometry (fibroscan) in recurrent HCV infection in liver transplant recipients (2006) (2)
- [Late-appearing cholestatic icterus after a month of treatment with ticlopidine]. (2001) (2)
- Sonographic diagnosis of adult intussusception (2001) (2)
- OC-13 Radiofrequency ablation versus hepatic resection for early hepatocellular carcinoma: a cost-effectiveness perspective (2013) (2)
- 968 IMPACT OF GADOXETIC ACID (GD-EOB-DTPA)-ENHANCED MAGNETIC RESONANCE ON THE NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA (2011) (2)
- Squamous cell carcinoma of the liver: metastasis or primary neoplasm? (2005) (2)
- Sonographic evaluation of the portal venous system after elective endoscopic sclerotherapy of esophageal varices (2004) (2)
- Epidemiology and Clinical Features of Hepatocellular Carcinoma (1999) (2)
- Metronomic capecitabine as second-line treatment for patients with hepatocellular carcinoma with preserved liver function: A phase II study. (2011) (2)
- Daily modifications of splanchnic hemodynamics (SH) in cirrhotics with different degree of variceal bleeding (VB) risk (1995) (2)
- The role of gastroenterologists and digestive surgeons in ultrasonography. (1992) (2)
- Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (2017) (2)
- Heart failure and chronic kidney disease in a registry of internal medicine wards (2014) (2)
- Interobserver and arterial Doppler interequipment variability of hepatic, splenic, and renal resistance indices in normal subjects and patients with cirrhosis (1997) (2)
- Intraoperative ultrasound during pancreatic surgery (1989) (1)
- OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B) (2013) (1)
- A case of intractable pruritus in Turner’s syndrome successfully treated with molecular adsorbent recirculating system (2008) (1)
- Treatment of small hepatocellular carcinoma (HCC) by percutaneous ethanol injection (PEI) (1989) (1)
- 271 MIR-221/MDM2/P53 CONTROL LOOP SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO ANTI-CANCER TREATMENTS (2012) (1)
- Perfusional angiosonography with a second generation ultrasound contrast agent in the characterization of small nodules in cirrhosis (2003) (1)
- Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study) (2020) (1)
- Cardiac abnormalities in cirrhosis. (2001) (1)
- Color Doppler Endosonography in the Study of Portal Hypertension (1992) (1)
- OC-27 Diagnostic accuracy of different patterns of contrast enhanced ultrasound in characterization of new nodules in liver cirrhosis with and without history of previous hepatocellular carcinoma (2011) (1)
- Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma (2014) (1)
- Clinical predictors of response to sorafenib in patients with hepatocellular carcinoma. (2013) (1)
- IMP 1211 Splanchnic and systemic hemodynamic response to meal in cirrhotics with different bleeding risk (1997) (1)
- Portal pressure and Doppler. (2003) (1)
- HEADACHE: PREVALENCE OF A NEW CARDIOVASCULAR RISK FACTOR IN PATIENTS WITH ARTERIAL HYPERTENSION: PP.42.351 (2011) (1)
- [Therapeutic effect of a pharmacologic combination of choleretics and digestive enzymes in exocrine pancreatic insufficiency]. (1975) (1)
- Timing of postprandial hemodynamic events in cirrhosis (1989) (1)
- 340 Expression of the components of the notch signaling pathway in neoplastic and cirrhotic human liver (2004) (1)
- Targeted Therapies for Hepatocellular Carcinoma (2012) (1)
- Notch 3 Intracellular Domain Accumulates in HepG 2 Cell Line (2008) (1)
- Corrigendum to "Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study" [Dig. Liver Dis. 49 (2017) 802-808]. (2018) (1)
- Advances in diagnostic imaging: The value of contrast-enhanced ultrasound for liver (2006) (1)
- Hepatic artery resistance in portal vein thrombosis. (1996) (1)
- Brivanib in combination with Notch3 silencing shows potent activity in tumour models (2019) (1)
- PRELIMINARY RESULTS OF METRONOMIC CAPECITABINE TREATMENT IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC). (2007) (1)
- Orthotopic liver transplantation (OLT): Contribution of diagnostic imaging and interventional radiology in preparing the transplantation and managing complications. Part 1: Indications, surgical technique, diagnostic imaging and interventional radiology before transplantation from cadaveric and livi (2005) (1)
- Endoscopic sonography of the esophagus (1989) (1)
- 209 MICRORNA-519D IS UP-REGULATED IN HEPATOCELLULAR CARCINOMA AND SENSITIZES HCC CELLS TO DOXORUBICIN TREATMENT BY TARGETING CDKN1A/P21 (2011) (1)
- TACE performed in patients with a single nodule of Hepatocellular Carcinoma (2014) (1)
- Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery (1996) (1)
- Editorial: Cigarette smoking, abdominal blood flow and abdominal diseases (1996) (1)
- Gallstone ileus in Caroli's disease. (2000) (1)
- POST-MARKETING RETROSPECTIVE ANALYSIS ON THE SAFETY OF SONOVUE, A SECOND GENERATION ULTRASOUND CONTRAST AGENT, IN ABDOMINAL APPLICATIONS. REPORT FROM 23.188 PATIENTS STUDIED IN ITALY (2005) (1)
- Changes of hepatic venous flow in liver disease assessed by Doppler US. relationship with histology (1991) (1)
- Evaluation of efficacy of antiangiogenic treatment using US-based techniques in a murine model of hepatocellular carcinoma (HCC) under different treatment schedule (2013) (1)
- 136 Artificial neural network is superior to meld in predicting mortality of patients with end-stage liver disease (2006) (1)
- Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease (2022) (1)
- Moderate alcohol consumption is associated with risk of fibrosis in patients with non-alcoholic fatty liver disease (2020) (1)
- Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. (2009) (1)
- Pharmacokinetic of lansoprazole in cirrhotics with different degree of liver function derangement (1995) (1)
- A Case of Antibiotic-Resistant Dorsal Hand Purulent Tenosynovitis Diagnosed by Ultrasound Post Liver Transplant (2009) (0)
- Evaluation of the prevalence of spontaneous hepatofugal flow in the portal venous system in patients with liver cirrhosis (1989) (0)
- Development of a nomogram based on clinical factors for prediction of significant fibrosis in chronic hepatitis C patients (2009) (0)
- Image-directed ablative treatments for HCC (2005) (0)
- Contents, Vol. 29, 1984 (1984) (0)
- Medical Treatment of Hepatocellular (2009) (0)
- Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease (2018) (0)
- Diagnostic accuracy of liver and spleen stiffness measurement for portal hypertension using bidimensional shear weave elastography (2015) (0)
- Subject Index, Vol. 29, 1984 (1984) (0)
- Introduzione a "The Value of Contrast-Enhanced Ultrasound for Liver" (2006) (0)
- Doppler US and contrast-enhanced perfusional angiosonography in hepatocellular carcinoma. (2004) (0)
- Brain diffusion weighted MRI in cirrhosis (2003) (0)
- Correspondence (0)
- Changes in Tumor Stiffness for Early Prediction of Tumor Response to Sorafenib: A Proof-of-Concept Study with Elastosonography in an Animal Model of Hepatocellular Carcinoma (HCC) (2011) (0)
- Contents Vol. 32, 2014 (2014) (0)
- FRI-475-Experience impacts on reasons leading to sorafenib discontinuation and chance of long-term response tyrosine-kinase inhibitors, as these molecules share a common toxicity-profile. (2019) (0)
- 538 NOTCH3 DOWN-REGULATION INCREASES THE SENSITIVITY OF HEPG2 LIVER CELLS TO DOXORUBICIN (2008) (0)
- Contents Vol. 33, 2015 (2015) (0)
- Interesting antitumor activity of lenalidomide in a patient with hepatic epithelioid hemangioendothelioma (HEH). (2013) (0)
- FRI-500-Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: Intrinsic resistance or not? (2019) (0)
- [Ascites in chronic pancreatitides. Report of 2 cases]. (1977) (0)
- Duplex Doppler evaluation of cystic veins in pre-hepatic portal hypertension (1988) (0)
- BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function (2021) (0)
- Issue Information (2018) (0)
- LEFT VENTRICULAR FUNCTION IN LIVER CIRRHOSIS. AUTHORS' REPLY (1996) (0)
- HEPATIC ARTERY RESISTANCE IN PORTAL VEIN THROMBOSIS. AUTHOR'S REPLY (1996) (0)
- 659 Analysis of Efficacy Improvement of Repeated Tace for Hcc (2011) (0)
- Multiple abdominal abscesses complicated by severe sepsis as a result of occult Crohn’s disease (2014) (0)
- Incidence of late HCC recurrence after resection remains higher than first HCC: Implications for patients management (2008) (0)
- Perfusional angiosonography in the detection of hypervasculariy in small (<3cm) HCC in cirrhosis (2003) (0)
- Mortality prediction with transient elastography after liver transplantation for liver failure of various aetiologies (2014) (0)
- Potassium kanrenoate decreases the incidence of portal hypertension-related complications in compensated cirrhosis. A double-blind randomized study. (2004) (0)
- Percutaneous radio-frequency ablation of small HCC: Factors related to clinical outcome and recurrence of disease (2008) (0)
- Presence of onconeural antibodies in cancer and non-cancer patients with recent psychophysical decline. (2012) (0)
- Pattern of enhancement timing in focal nodular hyperplasia (FNH) investigated by perfusional angiosonography (2003) (0)
- 402 INCIDENCE OF LATE (<2 YEARS) HCC RECURRENCE AFTER SURGICAL RESECTION REMAINS HIGHER THAN OF FIRST HCC IN CIRRHOSIS: IMPLICATIONS FOR PATIENTS MANAGEMENT (2008) (0)
- 327 MICRO-RNA-221 REGULATES P27/KIP1 IN HEPATOCELLULAR CARCINOMA (2008) (0)
- Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: A real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort (2016) (0)
- The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma (2018) (0)
- IMO 1228 Superior mesenteric artery Doppler impedance indexes in chronic liver diseases (1997) (0)
- Benign Liver Lesions. Clinico-pathologica classification. (2005) (0)
- Gallstone ileus in Caroli's disease: Ultrasound diagnosis (1998) (0)
- Appearance of combined hepatocellular cholangiocarcinoma in cirrhosis at contrast enhanced imaging techniques (2014) (0)
- 1015 THE CHALLENGE OF TREATING HCC IN CHILD-PUGH B: NEED FOR SUBCLASSIFICATION (2011) (0)
- 156 Proposal of a novel meld score adjustment for HCC patients waiting for liver transplantation (2006) (0)
- Relationship between serum levels of alfa-fetoprotein (AFP) and growth rate of hepatocellular carcinoma (HCC) (1989) (0)
- Feasibility of a focused ultrasound training course for medical undergraduate students (2013) (0)
- 34 MicroRNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT (2010) (0)
- [Enterorrhagia of ulcerated Meckel's diverticulum from the point of view of current diagnostic technics. Report of a case]. (1973) (0)
- Treatment type is an independent prognostic factor for patients with intermediate stage hepatocellular carcinoma (2014) (0)
- Prognostic factors for survival of small (≤5 cm) untreated hepatocellular carcinoma in the west (1991) (0)
- 249 CHANGES IN TUMOR STIFFNESS FOR EARLY PREDICTION OF TUMOR RESPONSE TO SORAFENIB: A PROOF-OF-CONCEPT STUDY WITH ELASTOSONOGRAPHY IN AN ANIMAL MODEL OF HEPATOCELLULAR CARCINOMA (HCC) (2011) (0)
- MiR-221 regulates p27/kip1 in hepatocellular carcinoma (2008) (0)
- Indications for Liver Transplantation (2015) (0)
- Splanchnic arterial doppler parameters in portal hypertension (1999) (0)
- Intra-operative ultrasonography: instrumentation and exploration technique (1989) (0)
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma : Subanalyses of a phase III trial q , qq (2012) (0)
- Doppler US in portal hypertension (1993) (0)
- SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma (2019) (0)
- ARTERIAL BLOOD PRESSURE CONTROL AND AGE: THE EXPERIENCE OF A SINGLE CENTRE: PP.44.407 (2011) (0)
- Reply to selected summary: Dilatation of the pancreatic duct (Gastroenterology 1985;88:1285–1286) (1985) (0)
- Use of perfusional angiosonography in liver transplantation and conservatve management of post‐transplant intra‐hepatie pseudo‐aneurysm (2004) (0)
- P972 SINGLE HEPATOCELLULAR CARCINOMA: IS TACE A VALID OPTION? (2014) (0)
- 1043 IN HEPATOCELLULAR CARCINOMA miR-494 IS REGULATED BY EPIGENETIC MECHANISMS AND TARGETS p27, PTEN AND PUMA (2013) (0)
- 2 PS Collagenase-3 expression in liver tumors (2002) (0)
- P586 APPEARANCE OF COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA IN CIRRHOSIS AT CONTRAST ENHANCED IMAGING TECHNIQUES (2014) (0)
- [Endoscopic treatment of obstructive cholangitis]. (1980) (0)
- Point Shear Wave Ultrasound Elastography to quantify liver stiffness with Esaote MyLab Twice compared to 2D-Shear Wave Elastography with Supersonic Imaging (2016) (0)
- [227] CONTRAST ENHANCED ULTRASOUND WITH SONOVUE. A NEW TOOL TO DETECT PERITONEAL-PLEURAL COMMUNICATIONS IN CIRRHOTIC PLEURASCITES (2007) (0)
- Improved sorafenib activity on hepatocellular carcinoma in Notch3 silenced in vivo and in vitro models. (2012) (0)
- 199 AUTOANTIBODIES SCREENING BY PROTEIN MICROARRAY: AN INNOVATIVE SOURCE OF CIRCULATING DIAGNOSTIC MARKERS FOR HEPATOCELLULAR CARCINOMA (2011) (0)
- T-17 Impact of Gadoxetic acid (Gd-EOB-DTPA)-enhanced MR on the non-invasive diagnosis of small hepatocellular carcinoma (2011) (0)
- [Combined stimulation of the beta cells in chronic pancreatitis]. (1979) (0)
- 304 PCNA Expression in human hepatocellular carcinoma: An in vivo and in vitro proteomic approach (2006) (0)
- T-10 MiR-221/Mdm2/p53 control loop sensitizes hepatocellular carcinoma cells to anti-cancer treatments (2012) (0)
- Fatty liver disease predicts insulin resistance and is more frequent in primary hypertension (2002) (0)
- OC-1 Prospective Italian multicenter field-practice study with sorafenib for advanced hepatocellular carcinoma (2011) (0)
- ARTERIAL HYPERTENSION AND DIABETES MELLITUS IN LIVER CIRRHOSIS:THE EXPERIENCE OF A SINGLE CENTRE: PP.1.32 (2011) (0)
- Validation of a new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma in a European cohort (2015) (0)
- Doppler tissue characterization of small hepatic tumors. Comparison between doppler spectral analysis and color-power doppler flow imaging (1998) (0)
- EFSUMB Honorary Members (2016) (0)
- Aberrant FHIT transcripts in hepatocellular carcinoma and liver cirrhosis (1998) (0)
- Author ' s response to reviews Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal Title : cancer (2007) (0)
- MicroRNA-199a-3p targets mTOR in human hepatocellular carcinoma (2009) (0)
- Survival of patients with hepatocellular carcinoma (HCC) within the Bologna Liver Oncology Group: comparison with international guidelines (2015) (0)
- Intraoperative ultrasound during bile tract surgery (1989) (0)
- 155 Prediction of significant fibrosis in HCV-infected liver transplant recipients by artificial neural network analysis of clinical factors (2006) (0)
- Ultrasound-measured visceral adipose tissue correlates with risk factors, severity and co-morbidities of NAFLD better than waist circumference (2017) (0)
- T-50 In hepatocellular carcinoma miR-519d is upregulated by p53 and DNA hypomethylation (2012) (0)
- Characterization of small nodules in liver cirrhosis. The assessment of the vascular pattern at imaging techniques. The problem of "hypovascular" HCC (2004) (0)
- [Evaluation of dimethicone on the meteorism symptom. Clinical and echotomographic observations]. (1984) (0)
- F-26 Changes in tumor stiffness for early prediction of tumor response to sorafenib: a proof-of-concept study with elastosonography in an animal model of hepatocellular carcinoma (HCC) (2011) (0)
- F-56 Evaluation of efficacy of antiangiogenic treatment in a murine model of hepatocellular carcinoma under different treatment schedules (2013) (0)
- 240 HEPATOCELLULAR CARCINOMA CELL LINES SECRETÓME AS A SOURCE OF POTENTIAL BIOMARKERS (2011) (0)
- Predictive value of hepatofugal flow for rick on bleeding and survival rate in liver cirrhosis (1990) (0)
- Ahead of print History of Ultrasound in Medicine from its birth to date (2022), on occasion of the 50 Years Anniversary of EFSUMB historical medical ultrasound (2022) (0)
- T-37 Mortality prediction with transient elastography in recurrent-HCV infection after liver transplantation (2013) (0)
- Growth rate of small (≤ 5 cm) untreated hepatocellular carcinoma in the west (1991) (0)
- Perfusional echoangiography for the diagnosis of liver lesions (2003) (0)
- Physical principles and instrumentation (1989) (0)
- F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA (2010) (0)
- F-3 Notch3 silencing and sorafenib as combinate treatment for human hepatocellular carcinoma (2012) (0)
- Loss of Heterozygosity of the Long Arm of Chromosome 16 in Hepatocellular Carcinoma on Liver Cirrhosis (1996) (0)
- Notch signaling pathway regulates P57KIP2 expression in human hepatocellular carcinoma (2009) (0)
- T-23 Splenic stiffness assessed by ARFI (acoustic radiation force impulse) correlates with portal pressure in liver cirrhosis (2012) (0)
- T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA (2010) (0)
- Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation (2007) (0)
- P0143 : Impulsional, point and bidimensional shear wave elastometry for portal hypertension: same stiffness thresholds? (2015) (0)
- Contrast enhanced ultrasound in diagnosis of hepatocellular carcinoma (HCC): role of wash-out in portal and late phases (2008) (0)
- EVELOPMENT OF A NOMOGRAM BASED ON LINICAL FACTORS FOR PREDICTION OF SIG- IFICANT FIBROSIS IN CHRONIC HEPATITIS C ATIENTS (2009) (0)
- Phase I/II trial of continuous hepatic arterial infusion (HAI) of Irinotecan in patients with hepatocellular carcinoma (HCC). Preliminary results. (2006) (0)
- 9.15 Hypertension and Metabolic Syndrome after Liver Transplantations (2008) (0)
- Arterial blood gas analysis after 120 minutes of noninvasive positive pressure ventilation can predict outcome in acute cardiogenic pulmonary oedema (2012) (0)
- Liver transplantation restores systemic and regional circulatory alterations of cirrhosis after a 24 months long follow-up (1998) (0)
- F.N.26 Efficacy of Superselective Tace in Treatment of Hcc (2010) (0)
- [Ultrasound staging research of progressive pathology of the base of the tongue]. (1992) (0)
- Relationship between portal venous flow assessed by doppler us and oesophageal varices in patients with cirrhosis and portal hypertension (1989) (0)
- Caspase-3 targeting: A further tile sustaining the anti-apoptotic role of miR-221 in hepatocellular carcinoma (2014) (0)
- 964 MECHANISMS OF P53 REGULATION BY NOTCH SIGNALLING IN HUMAN HEPATOCELLULAR CARCINOMA (2010) (0)
- P-650: Cardiovascular risk factors and cognitive and affective impairment in the elderly (2001) (0)
- 417 VIRTUAL TOUCH ASSESSMENT OF LIVER STIFFNESS IN CHRONIC LIVER DISEASE: COMPARISON WITH TRANSIENT ELASTOGRAPHY (2010) (0)
- Perfusional pattern analysis of contrast enhanced ultrasound (CEUS) improves diagnostic accuracy and reproducibility (2009) (0)
- 246 NOTCH SIGNALING PATHWAY REGULATES P57KIP2 EXPRESSION IN HUMAN HEPATOCELLULAR CARCINOMA (2009) (0)
- 1001 RAPID, MARKED WASH OUT AT CONTRAST ENHANCED ULTRASOUND IN NODULES IN CIRRHOSIS SHOULD RAISE THE SUSPICION OF CHOLANGIOCARCINOMA (2011) (0)
- Impulsional, point and bidimensional share wave elastometry for portal hypertension: same stiffness threshold? (2015) (0)
- Non-organ specific and organ-related autoantibodies in patients with colorectal cancer and in patients with cancer at other sites. (2012) (0)
- [Recent acquisitions on the etiopathogenesis of Whipple's disease. Report of a case with isolation of Klebsiella pneumoniae from the intestinal mucosa]. (1974) (0)
- Different clinical patterns of hepatocellular carcinoma (HCC) in patients with NAFLD and HCV related chronic liver disease (2015) (0)
- A case of inflammatory ascites (2014) (0)
- 1074 EVALUATION OF EFFICACY OF ANTIANGIOGENIC TREATMENT IN A MURINE MODEL OF HEPATOCELLULAR CARCINOMA UNDER DIFFERENT TREATMENT SCHEDULES (2013) (0)
- 11 VIRTUAL TOUCH ASSESSMENT OF LIVER CIRRHOSIS IN CHRONIC LIVER DISEASE DURING CONVENTIONAL ULTRASOUND SCANNING (2010) (0)
- [Control of the patency of porto-systemic anastomoses]. (1981) (0)
- Gastrointestinal Cancer (2019) (0)
- Venous Doppler findings are commonly detectable also in focal nodular hyperplasia with modern ultrasound equipments (2008) (0)
- The Appropriate Allocation of CEUS in the Diagnostic Algorithm of Liver Lesions: A Debated Issue (2013) (0)
- 240 MICRORNA-221 TARGETS BMF AND CORRELATES WITH TUMOR MULTIFOCALITY IN HUMAN HEPATOCELLULAR CARCINOMA (2009) (0)
- F-53 In hepatocellular carcinoma miR-494 is regulated by epigenetic mechanisms and targets p27, PTEN and PUMA (2013) (0)
- P996 PROPOSAL FOR AN UPDATE OF THE BARCELONA STAGING SYSTEM FOR HEPATOCELLULAR CARCINOMA BASED ON THE ROLE OF PERFORMANCE STATUS (2014) (0)
- Mortality prediction with transient elastography in recurrent-HCV infection after liver transplantation (2013) (0)
- 963 CDKN1C/P57 INDUCES CELL SENESCENCE AND IS REGULATED BY NOTCH TARGET GENE HES1, A PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA (2010) (0)
- Non-inyasive doppler us evaluation of portal flow in posthepatitic (HC), alcoholic (AC) and primary biliary (PBC) cirrhosis (1989) (0)
- Ultrasonography in the Differential Diagnosis between Intra- and Extrahepatic Cholestasis (1979) (0)
- Liver stiffness fibrosis thresholds of Fibroscan cannot be adopted by all new elastography machines: A comparative study (2017) (0)
- MicroRNA-221 targets BMF and correlates with tumor multifocality in human hepatocellular carcinoma (2009) (0)
- Cost-effectiveness of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma (2009) (0)
- Front & Back Matter (2012) (0)
- [Pitfalls of cardiologic consultation in internal medicine: an obvious case of alcoholic liver cirrhosis]. (2008) (0)
- Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: a validation study of the HAP and SAP scores (2018) (0)
- Liver transplantation does not completely correct the haemostatic abnormalities of cirrhotic patients (2007) (0)
- 811 COST-EFFECTIVENESS OF RECALL STRATEGIES FOR NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA (2009) (0)
- Brandi-13-93 (2014) (0)
- Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis - Authors' reply. (2017) (0)
- [Pancreatic echotomography : use, value and limits in the diagnosis of chronic pancreatitis]. (1975) (0)
- F-16 Applicability of international guidelines in the therapeutic algorithm of hepatocellular carcinoma (2012) (0)
- 933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT (2010) (0)
- Tissue characterization of small hepatic tumors. Quantitative doppler spectral analysis vs. power doppler flow imaging (1998) (0)
- [Role of grey scale echotomography in the diagnosis of liver diseases]. (1977) (0)
- Risk factors for significant fibrosis differently affect patients with non-alcoholic liver disease depending on gender (2020) (0)
- [Criteria and trends in medical therapy in chronic pancreatitis]. (1977) (0)
- [Use of gray-scale echography in the diagnosis of hepatic lesions--comparison with laparoscopy]. (1977) (0)
- Intraoperative ultrasonography during liver surgery (1989) (0)
- PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN HYPERTENSIVE PATIENTS: P1.45 (2000) (0)
- OC-3 MicroRNA-519d is up-regulated in hepatocellular carcinoma and sensitizes HCC cells to Doxorubicin treatment by targeting CDKN1A/p21 (2011) (0)
- 17 OC Recurrence after percutaneous radio-frequency thermal ablation in previously treated and untreated hepatocellular carcinoma (2002) (0)
- Doppler Ultrasound in Hepatic Hemodynamics (1991) (0)
- Prospective down-staging protocol for HCC not meeting the Milan criteria (2006) (0)
- Notch3 down-regulation increases the sensitivity of HepG2 liver cells to doxorubicin (2008) (0)
- Management of liver cirrhosis and prognostic classification of hepatocellular carcinoma (2009) (0)
- Intraoperative ultrasound during surgery for portal hypertension and liver transplantation (1989) (0)
- Appearance and spontaneous regression of a urinoma in the absence of hydronephrosis during acute obstructive renal disease (1998) (0)
- Impact of anticoagulation on the evolution of portal vein thrombosis in cirrhosis: a retrospective analysis (2015) (0)
- Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors (2007) (0)
- Reliability of Ultrasound Screening of Liver and Kidney Donors: A Retrospective Study (2000) (0)
- [Renal angiomyolipoma. Analysis of a clinical case in the light of current diagnostic possibilities]. (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Luigi Bolondi?
Luigi Bolondi is affiliated with the following schools:
